Go to main navigationGo to contentGo to footer

External link

You are now leaving the Grünenthal Foundation website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Grünenthal Foundation team: Tom Hermes, Dr. Stephan Frings, Susanne Schmitt-Degenhardt, Patrick Thevis

Being there for Thalidomide-affected people – that is our mission and our driving force.

Our work is shaped by a team driven by a profound sense of moral responsibility – acting with respect, dedication, and genuine commitment to every person affected.

The Grünenthal Foundation for the support of Thalidomide-affected people

The Foundation was established in 2012. Its purpose is to bring about a lasting improvement in the lives of Thalidomide-affected people.

Listen. Support. Empower.

The present and future of Thalidomide-affected people are at the heart of our work. We listen to truly understand needs and provide targeted support where it matters most in everyday life.

In addition to existing financial assistance, people affected by Thalidomide can receive the following support from us:

Home environment adaptations

We all want a home where we feel safe and comfortable. However, living spaces are not usually designed for the needs of people with disabilities. We support you in adapting your living space to your individual needs.

Vehicle conversions

Having your own vehicle ensures independent mobility and supports participation in social life. For this reason, our foundation provides funding for expanded equipment options and vehicle conversions.

Personal accompaniment

Travel is important for everyone, including Thalidomide-affected people. It plays a key role in enabling people to visit family and friends, experience new things, and leave their everyday routines behind. For people affected by Thalidomide, even taking a walk in their own neighbourhood can be challenging. For this reason, we provide support for travel and other activities outside the home.

News

Grünenthal Foundation at the ‘Egmond Circle’

From 26 October to 2 November 2026, the international ‘Egmond Circle’ congress for people affected by Thalidomide will take place in Egmond aan Zee, the Netherlands. The Grünenthal Foundation for the support of Thalidomide-affected people is providing financial support for the event, and the Foundation team will be on site.

The congress brings together people affected by Thalidomide from different countries to exchange views on issues relating to health, participation and ageing while living with severe disabilities. International experts from various medical fields will share current therapeutic insights and exchange views with participants.

The Grünenthal Foundation for the support of Thalidomide-affected people will have an information stand at the event, where the team will be available for personal conversations and to answer questions about the Foundation’s work and the support it provides. We look forward to meeting you in person in Egmond aan Zee.

All important information about the congress is available on the organiser’s website: ‘Egmond Circle’ congress